Asghar, K., & Loya, A. (2018). INDOLEAMINE 2,3 DIOXYGENASE AS AN IMMUNOTHERAPEUTIC TARGET BRINGS A NEW HOPE FOR CANCER PATIENTS. Journal of Cancer & Allied Specialties, 4(3). https://doi.org/10.37029/jcas.v4i3.175